Novo Nordisk A/S (NVO) Social Stream



Novo Nordisk A/S (NVO): $79.64

-0.94 (-1.17%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Featured Post From StockTwits About NVO

The Daily Biotech Pulse: Merck Reports Positive Keytruda Data In Breast Cancer, Curis, Evoke Slump On Earnings, Qiagen's Rapid COVID-19 Antibody Test OK'ed For Emergency Use https://benzinga.com/z/21102045#.YJ0Xjl-mad0.twitter $IBB $NVO $EVOK
Benzinga, published May 13, 2021

What Else are NVO Traders Talking About?


Other tickers frequently mentioned alongside NVO are IBB, EVOK, MNKD and LLY.

Other Notable StockTweets About NVO


Are the daytraders watching this? $NVO enters an Uptrend because Momentum Indicator exceeded the 0 level on April 7, 2021. View odds for this and other indicators: https://srnk.us/go/2691874

tickeron, published April 24, 2021

$MNKD $NVO $LLY $SNY

Why are physicians still prescribing the antiquated, barbaric subcutaneous mealtime insulins?

Afrezza is the world’s only:

• inhaled insulin

• ultra rapid acting insulin

• insulin that matches physiologic insulin like that seen in a healthy, non-diabetic person

• insulin that does not cause insulin-derived amyloidosis

• insulin that does not cause lipohypertrophy

• insulin that is weight neutral

• insulin that restores post-prandial glucose homeostasis

• insulin that mimics the first phase insulin response

• insulin that causes no pain

mango3, published April 15, 2021

$AEZS somebody recently made a comment to me on here regarding Macimorelin for CGHD and that if AGHD is only generating $x why should we expect CHGH to be any better? Well clearly this person had not done any research into the disease. Attached is taken from our EU partner Consilient Health- as you can see just by the nature of the disease, its clearer the need to diagnose is much higher in children then it is adults. Therefore the addressable market is so much larger! So entering our pivotal PO2 trials this month is such a significant step for the development on this diagnostic drug! We already have it approved for AGHD so in reality clearing the pathway for CHGD will be much easier... and as a reminder it is being funded by $NVO - you think they are just investing 9M Euro's into this study for shits and giggles? Fuck no! I am still here long and strong!

MrVunderfull, published April 7, 2021

Loading social stream, please wait...


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 1.6747 seconds.